Home
Portfolio
News
Contact
Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity
Kailera
related
news
ADARx Pharmaceuticals raises 4.463 million in upsized US IPO
Reuters
September 25 2026
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
NASDAQ
July 14 2026
Get In Touch
Contact Us